Rescue Medication in Acute Migraine Treatment: Results of Phase 3 Trial
An orally inhaled dihydroergotamine studied for the rescue treatment of acute migraine exhibited significant pain relief compared with placebo, according to the results of a pivotal phase 3 trial presented at PAINWeek 2012